bullish

Trading Strategy for SK Biopharm Post IPO Pricing

368 Views19 Jun 2020 21:54
SK Biopharm announced its stellar IPO book building results today. The IPO price has been confirmed at 49,000 won, which is at the high end of the...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Douglas Kim
Korea/Asia, Events, IPOs
Douglas Research Advisory
South KoreaEquity Bottom-UpEquity Capital Markets
x